Cooper Companies Inc (NYSE:COO) Director Gary S. Petersmeyer sold 430 shares of the business’s stock in a transaction that occurred on Friday, June 22nd. The stock was sold at an average price of $234.33, for a total transaction of $100,761.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of Cooper Companies stock opened at $234.00 on Tuesday. The firm has a market capitalization of $11.65 billion, a PE ratio of 21.68, a price-to-earnings-growth ratio of 1.87 and a beta of 0.61. Cooper Companies Inc has a 12 month low of $216.47 and a 12 month high of $260.26. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 2.76.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, June 7th. The medical device company reported $2.86 EPS for the quarter, beating analysts’ consensus estimates of $2.84 by $0.02. The business had revenue of $631.30 million for the quarter, compared to analysts’ expectations of $627.49 million. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. The company’s quarterly revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the company posted $2.50 EPS. equities research analysts expect that Cooper Companies Inc will post 11.81 EPS for the current fiscal year.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Mount Yale Investment Advisors LLC acquired a new position in Cooper Companies in the 1st quarter valued at $422,000. Suntrust Banks Inc. increased its stake in Cooper Companies by 30.4% in the 1st quarter. Suntrust Banks Inc. now owns 2,667 shares of the medical device company’s stock valued at $609,000 after buying an additional 621 shares during the period. Redwood Investments LLC acquired a new position in Cooper Companies in the 1st quarter valued at $3,673,000. Allianz Asset Management GmbH increased its stake in Cooper Companies by 36.5% in the 1st quarter. Allianz Asset Management GmbH now owns 202,613 shares of the medical device company’s stock valued at $46,359,000 after buying an additional 54,143 shares during the period. Finally, Amalgamated Bank increased its stake in Cooper Companies by 4.8% in the 1st quarter. Amalgamated Bank now owns 10,845 shares of the medical device company’s stock valued at $2,481,000 after buying an additional 493 shares during the period. 96.85% of the stock is currently owned by institutional investors.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.